A COMPARISON OF THE EFFECT OF COMMERCIAL

Similar documents
Immunohistochemistry in Breast Pathology- Brief Overview of the Technique and Applications in Breast Pathology

Dr. dr. Primariadewi R, SpPA(K)

Assessment Run B HER-2 IHC. HER-2/chr17 ratio**

Estrogen Receptor, Progesterone Receptor, and Her-2/neu Oncogene Expression in Breast Cancers Among Bangladeshi Women

Assessment Run B HER2 IHC

Received 04 November 2008; Accepted in revision 09 January 2009; Available online 20 January 2009

T he HER2/neu type 1 tyrosine kinase growth factor

HER2 status assessment in breast cancer. Marc van de Vijver Academic Medical Centre (AMC), Amsterdam

Immunohistochemical Expression of Hormone Receptors and The Histological Characteristics of Biochemically Hormone Receptor Negative Breast Cancers

Patterns of E.cadherin and Estrogen receptor Expression in Histological Sections of Sudanese Patients with Breast Carcinoma

KEY WORDS: Breast carcinoma, c-erbb2, Fluorescent. Mod Pathol 2001;14(11):

Assessment Run B HER2 IHC

HercepTest for the Dako Autostainer Code K5207

# Best Practices for IHC Detection and Interpretation of ER, PR, and HER2 Protein Overexpression in Breast Cancer

Int J Clin Exp Pathol 2017;10(3): /ISSN: /IJCEP

Comparison of Immunohistochemical and Fluorescence In Situ Hybridization Assessment of HER-2 Status in Routine Practice

IMMUNOHISTOCHEMICAL EXPRESSION OF TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) IN INVASIVE BREAST CARCINOMA

Estrogen receptor (ER)

Evaluation of antigen retrieval buffer systems

Assessment Run CK19

Welcome! HER2 TESTING DIAGNOSTIC ACCURACY 4/11/2016

HercepTest TM Code K5204

Journal of Breast Cancer

Interpretation Manual - Gastric or Gastroesophageal Junction Adenocarcinoma. PD-L1 IHC 22C3 pharmdx is FDA-approved for in vitro diagnostic use

ISPUB.COM. C Choccalingam, L Rao INTRODUCTION ESTROGEN AND PROGESTERONE RECEPTORS

HRP cytochemistry. Division of Radiooncology, Deutsches Krebsforschungszentrum, Heidelberg, Germany

Priti Lal, MD, 1 Paulo A. Salazar, 1 Clifford A. Hudis, MD, 2 Marc Ladanyi, MD, 1 and Beiyun Chen, MD, PhD 1. Abstract

Assessment Run GATA3

Assessment Run C1 2017

Cell Culture. The human thyroid follicular carcinoma cell lines FTC-238, FTC-236 and FTC-

Product Introduction

HER2 ISH (BRISH or FISH)

Estrogen receptor (ER)

Correlation Between GATA-3, Ki67 and p53 Expressions to Histopathology Grading of Breast Cancer in Makassar, Indonesia

Product Introduction. Product Codes: HCL029, HCL030 and HCL031. Issue

Immunohistochemical (IHC) HER-2/neu and Fluorescent- In Situ Hybridization (FISH) Gene Amplification of Breast Cancer in Indian Women

Guideline. Associated Documents ASCO CAP 2018 GUIDELINES and SUPPLEMENTS -

Immunohistochemical Determination of HER-2/neu Expression in Invasive Breast Carcinoma

Results you can trust

Next-Generation Immunohistochemistry: Multiplex tissue imaging with mass cytometry

Immunohistochemistry on Fluid Specimens: Technical Considerations

The Effect of Delay in Fixation, Different Fixatives, and Duration of Fixation in Estrogen and Progesterone Receptor Results in Breast Carcinoma

Optimal algorithm for HER2 testing

Formaldehyde scavengers function as novel antigen retrieval agents

Carcinoembryonic antigen (CEA)

HER2/neu Amplification in Breast Cancer Stratification by Tumor Type and Grade

Novocastra Liquid Mouse Monoclonal Antibody MyoD1 (Rhabdomyosarcoma Marker)

Single and Multiplex Immunohistochemistry

HER-2 Protein Overexpression in Metastatic Breast Carcinoma Found at Autopsy

Kristen E. Muller, DO, Jonathan D. Marotti, MD, Vincent A. Memoli, MD, Wendy A. Wells, MD, and Laura J. Tafe, MD

Technique and feasibility of a dual staining method for estrogen receptors and AgNORs

Mapping Basal Cell and Squamous Carcinoma By 10 Min CK5 Direct Immunohistochemistry on Frozen Section Skin Tissues during Mohs Micrographic Surgery

Characterization and significance of MUC1 and c-myc expression in elderly patients with papillary thyroid carcinoma

Brief Formalin Fixation and Rapid Tissue Processing Do Not Affect the Sensitivity of ER Immunohistochemistry of Breast Core Biopsies

Assessment performed on Friday, September 18, 2015, at Vancouver General Hospital

A Retrospective Analysis of Clinical Utility of AJCC 8th Edition Cancer Staging System for Breast Cancer

High expression of fibroblast activation protein is an adverse prognosticator in gastric cancer.

CME/SAM. Abstract. Anatomic Pathology / HER2/neu Results in Breast Cancer

Supplementary Online Content

Urothelial Carcinoma (UC)

Assessment of Her-2/neu Overexpression in Primary Breast Cancers and Their Metastatic Lesions: An Immunohistochemical Study

Prostate Immunohistochemistry. Literature Interpretation: Caveats. Must be aware of staining pattern of antibody in the relevant tissue

Estrogen receptor (ER)

Novocastra Liquid Mouse Monoclonal Antibody Glial Fibrillary Acidic Protein

Appendix 1. A. Procedure for preparing histopathology slides. The liver removed and stored immediately in buffered formalin 10 % for

LIST OF ORGANS FOR HISTOPATHOLOGICAL ANALYSIS:!! Neural!!!!!!Respiratory:! Brain : Cerebrum,!!! Lungs and trachea! Olfactory, Cerebellum!!!!Other:!

Supplementary Appendix

Cytokeratin 19 (CK19)

Thyroid transcription factor-1 (TTF1) Assessment run

Research Article Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67

RCD24, B7-H4 and PCNA expression and clinical significance in ovarian cancer

Urothelial Carcinoma (UC)

Breast cancer diagnostic solutions Deliver diagnostic confidence

NordiQC External Quality Assurance in Immunohistochemistry

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Breast

Department of Pathology, University of Southern California Keck School of Medicine, Los Angeles, California

A Study to Evaluate the Effect of Neoadjuvant Chemotherapy on Hormonal and Her-2 Receptor Status in Carcinoma Breast

Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY

Prosigna BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY

HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer

Phospho-PRAS40 Thr246 predicts trastuzumab response in patients with HER2-positive metastatic breast cancer

Cost Effectiveness of Manual Tissue Microarray Technique in Diagnostic Immunohistochemistry

Epithelial cell-cell adhesion molecule (Ep-CAM)

RESEARCH ARTICLE. Wan Faiziah Wan Abdul Rahman 1 *, Mohd Hashairi Fauzi 2, Hasnan Jaafar 1. Abstract. Introduction

Comparison of HER2/neu Status Assessed by Quantitative Polymerase Chain Reaction and Immunohistochemistry

Evaluation the Correlation between Ki67 and 5 Years Disease Free Survival of Breast Cancer Patients

Comparison on Cell Block, Needle-Core, and Tissue Block Preparations

HER2 CISH pharmdx TM Kit Interpretation Guide Breast Cancer

(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-

Thyroid Stimulating Hormone (S-TSH) Thyroid Stimulating

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers

Expression of androgen receptors in primary breast cancer

Potential Value of Hormone Receptor Assay in Carcinoma In Situ of Breast

Expression and Significance of GRP78 and HER-2 in Colorectal Cancer

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Novocastra Liquid Mouse Monoclonal Antibody Multi-Cytokeratin (4/5/6/8/10/13/18)

Novocastra Liquid Mouse Monoclonal Antibody Myeloperoxidase

Incidence of brain metastases in HER2+ gastric or gastroesophageal junction adenocarcinoma.

Comparison of in situ hybridization methods for the assessment of HER-2/neu gene amplification status in breast cancer using a tissue microarray

Transcription:

African Journal of Cellular Pathology 6:1-5 (016) The Official Journal of the Society for Cellular Pathology Scientists of Nigeria www.ajcpath.com A COMPARISON OF THE EFFECT OF COMMERCIAL ph BUFFERS ON EPITOPE RETRIEVAL OF HER-/neu PROTEIN Enemari JO 1, Avwioro OG, Osadolor HB, Idoko J 1, Yaro JD 1, Odigie BE 1. Department of Pathology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria.. Faculty of Science, Delta State University, Abraka, Delta State, Nigeria.. Department of Medical Laboratory Science, University of Benin, Benin, Nigeria. Corresponding Author: Enemari JO Email: ojladi@yahoo.com ABSTRACT Aim: The significance of immunohistochemistry standardization became important with the disclosure of alarmingly high records of inconsistent results in the assessments of HER-/neu expression status in women with breast cancers. Formalin-Fixed-Paraffin-Embedded tissue usually presents with conformational macromolecular changes, masking the epitope with sub-optimal staining of HER- /neu protein. The ph of epitope retrieval solution appears to significantly influence the completion of the unmasking process. The present study therefore examines the impact of commercial buffers on epitope retrieval of HER-/neu protein so as to optimize diagnosis and management of breast cancers. Methods: The study examined three ph buffers, non-retrieved sections and distilled water as a control on a + HER-/neu FFPE tissue block by water-bath epitope retrieval procedure and subsequently stained immunohistochemically. Results: The ph of the buffers does not significantly influence the staining quality of HER-/neu protein. However, ph 6 appears to be the most optimal as associated with other buffers examined. Conclusion: ph 6 buffer in conjunction with water-bath procedure is strongly recommended as the first-choice buffer for epitope retrieval of HER-/neu protein. Keywords: ph, Buffers, Epitope Retrieval, HER-/neu, Immunohistochemistry INTRODUCTION The dire significance of Immunohistochemistry (IHC) standardization became apparent with the disclosure of alarmingly high records of discordant outcomes in assessments of Human Epidermal Growth Factor Receptor- (HER- /neu) expression which is key in taking treatment decisions for women with breast cancers. HER-positive status represents a major therapeutic target, since HER-/neu overexpression acts a central role in oncogenic alteration and tumourigenesis (Chazin, 199), and is related to poor prognosis with shortened disease-free and general survival (Slamon, 1987). HER/neu-positivity alone confers intermediate or high-risk status (Goldhirsch et al., 006). Women whose breast cancers overexpress HER/neu protein, i.e., 0-0% of breast cancers (Penault-Llorca et al., 005), with immunohistochemistry score of + gain the most clinical benefit from Herceptin (trastuzumab). It is vital that assessment of HER-/neu status must be accurate and of high quality. It is indeed necessary to accurately identify those patients who will profit from this management while avoiding futile treatment of patients who are unlikely to respond. False positive HER-/neu results can give rise to overtreatment of patients, raise false hope and waste resources while false negative results may deny women with breast cancer potentially lifeextending treatment. Central to immunohistochemistry of HER-/neu is the reaction of its antibody (monoclonal or polyclonal) with the matching epitope(s) on its antigen. This reaction is usually threatened due to precipitation reaction ensuing from formalin fixation and paraffin processing on the HER- /neu protein yielding cross-links (Dapson,

007), hence, masking the HER-/neu epitopes. For an optimal HER-/neu antigen/antibody complex to be established, the epitopes have to be unmasked. The procedure for epitope retrieval (ER) centered on heating to elevated temperatures is acknowledged to be useful for an efficient immunostaining of formal-fixed paraffin-embedded (FFPE) tissue sections (Igarashi et al., 1994). SDS-PAGE studies post heating the formaldehyde-treated protein, indicated that the core mechanism of heatinduced epitope retrieval (HIER) is centered on interfering with methylene bridges created by formaldehyde fixation (Emoto et al., 005). Heating, besides reversing epitope masking produced by formaldehyde in formalin-fixed paraffin sections, also uncover epitopes concealed due to molecular configuration of native molecules in frozen sections (Kakimoto et al., 008). Specifics of the mechanisms responsible for HIER is still vague but (Yashimata and Okada, 005) suggested that the ph of retrieval buffer is critical for appropriate refolding of antigens so that they are capable of reacting with antibodies. Cancer testing facilities in Nigeria do not have a standardized ph buffer for HER-/neu epitope retrieval. Commonly used buffers are any of these three (ph 6, 8 and 9). Therefore, the influence of ph on epitope retrieval of HER-/neu protein employing water-bath technique may not have been adequately explored. This study is thus significant to evaluate the optimal ph for epitope retrieval of HER-/neu protein in breast cancers. In this study, three buffers of different ph were examined to determine which gave the most optimal demonstration of HER-/neu protein. Working Hypothesis H 0 : The occurrence and re-occurrence of the high level of discordance in HER-/neu testing results are NOT associated with ph variation of its epitope retrieval buffer. H 1 : The emergence and re-occurrence of the high degree of discordance in HER-/neu testing results are related to the ph change of its epitope retrieval buffer. MATERIALS AND METHOD Tissue Block Formalin Fixed (10% Neutral Buffered Formalin) Paraffin-Embedded (FFPE) tissue block was retrieved from the archive of the Department of Pathology, Ahmadu Bello University Teaching Hospital, Zaria, Nigeria. Antibody Biomarker and Reagents A rabbit monoclonal antibody (Clone GR011) against HER-/neu used at a dilution of 1 in 80, (Genemed Biotechnologies South San Francisco, USA). Retrieval buffers ph 6, ph 8 and ph 9 (Leica, Germany). Section Preparation The tissue block with a + IHC score was sectioned at µm, mounted on Silane coated slides (Surgipath X-tra Slides sourced from Leica Biosystem). The slides were labeled as 5 groups of ph 6, 8, 9, distilled water as a control and a non-retrieved group (NR). Slides were baked at 100 C for hours and taken to distilled water. Preparation of Buffers 10X (stock solution) were diluted to 1X (working solution) using fresh distilled water into pre-labeled retrieval plastic jars. The ph of the respective buffers was validated using the ph meter (Hanna). A fourth jar containing distilled water was labeled as well. Procedure for Epitope Retrieval The plastic jars containing the epitope retrieval buffers were heated in the water-bath (DK-40, China) to 65 C. The slides were totally immersed in its corresponding pre-labeled jars and heated to 95 C, and the heating was maintained for 0 minutes at 95 C. The jars containing the section slides were cooled to room temperature for a further 0 minutes. Immunohistochemical Staining Procedure Sections labeled ph 6, ph 8, ph 9, distilled water and NR were covered in peroxidase block (Genemed, U.S.A.) to destroy endogenous peroxidase activity for 10 minutes and incubated with HER-/neu antibody (Genemed, U.S.A.) diluted 1:80 for 60 minutes, rinsed in PBS wash (Genemed, U.S.A.), the sections were incubated with mouse plus rabbit linker and with horseradish peroxidase (Genemed, U.S.A.) for 15 minutes each followed by washes of minutes each. The development of the chromogen was 5 minutes with, - diaminobenzidine hydrochloride (DAB) mixed equally with its substrate solution (Genemed, U.S.A.). Slides were then counterstained with Haematoxylin solution (Jallica Scientific, Zaria), drained and mounted with DPX.

Sections Evaluation for Immunoreactivity Staining immunoreactivity was categorized as 0, no immunoreactivity; 1+, incomplete membrane staining within < 10% of the invasive tumour cells; +, for incomplete circumferential membranous staining in > 10% of the invasive tumour cells and +, for complete intense circumferential membrane staining in > 0% of the tumour cells (Wolff et al., 01). Individual sections were assessed and evaluated by two trained medical laboratory scientists (JOE, JID), inconsistencies were deliberated until harmony was established. Appraisals of immunostaining scores were carried out at a matching locus on each stained section so as to circumvent any discrepancy due to the heterogeneity of protein distribution. RESULTS The outcomes are as abridged in Tables 1, and. Table 1: Dataset on influence of ph Buffers in epitope retrieval of Her-/Neu protein REPLICATIONS ph ph ph Distilled 6 8 9 water 1 + + + + 1+ + + + + 1+ + + + + 1+ 4 + + + + + 5 + + + 1+ + 6 + + + + + 7 + + + + + 8 + + + + + 9 + + + + + 10 + + + + + 11 + + + 1+ + 1 + + + + + NR SECTIONS Table : Mean and Standard Deviation of the different ph Buffers, Distilled Water as control and Non-Retrieved Sections ph 8 ph 9 Distilled NoN-Retrieved ph 6 (Mean SD) (Mean SD) Water Sections (Mean SD) (Mean SD) (Mean SD).666± 0.49.0± 0.49.500± 0.5.080± 0.669 1.917± 0.669 Table : Hypothesis Test Summary (Chi-square/one-sample Binomial) tests using SPSS1 Null Hypothesis Test Significance Decision 1 The categories defined by ph6 = and One-Sample 0.88 1 Retain the Null The categories defined by ph8 = and One-Sample 0.88 1 Retain the Null The categories defined by ph9 = and One-Sample 1.000 1 Retain the Null 4 The categories of distilled water occur One-Sample Chi- Retain the Null 0.174 with equal probabilities. Square Test 5 The categories of Non-Retrieved One-Sample Chi- Retain the Null 0.174 Sections occur with equal probabilities. Square Test Asymptotic significances are displayed. The level of significance is 0.05. 1 Exact significance is displayed for this test.

Staining Intensity ENEMARI ET AL.5 1.5 1 0.5 0 ph 6 (Mean) ph 8 (Mean) ph 9 (Mean) Distilled water (Mean) ph Variables and Controls Non Retrieved sections (Mean) Figure 1: Simple Bar Chart showing the relationship between mean staining intensity of HER-/neu protein and different ph Buffers, Distilled Water as control and Non-Retrieved Sections. Plate 1: HER-/neu stained sections retrieved at ph 6 (X100 Plate 4: HER-/neu stained sections retrieved using distilled water (X100 Plate : HER-/neu stained sections retrieved at ph 8 (X100 Plate 5: HER-/neu non-retrieved stained sections (X100 Plate : HER-/neu stained sections retrieved at ph 9 (X100 Immunohistochemical stained sections of the FFPE HER-/neu + tissue block show an insignificant difference in the circumferential staining intensity with all the retrieval buffers employed except for ph 6 (Plate 1) which displayed a little more circumferential staining intensity. DISCUSSION Buffer at ph 6 has been reported to be the most popular solution for HIER (Morgan et al., 1997). This is inconsistent with (Emoto et al., 4 005), which reported that Citrate buffer is not an ideal retrieval solution for a majority of antigens and (Gray et al., 007) reported the best quality staining with Dako buffer ph 9. This study established the highest mean staining value (.666) at ph 6 probably due to less

entangling of the tissue protein at acidic ph ionic strength; followed closely by ph 9 (.500) also probably due to more entangling of tissue protein presumably caused by increased hydrophobic forces; ph 8 (.0) and nonretrieved sections produced the least mean staining value (1.917). Distilled water at ph 7 yielded a low mean staining value of (.080) due to a highly entangled tissue protein, triggered by the concurrent existence of ionic and hydrophobic forces. A little mean staining value of 1.917 produced by Non-Retrieved Sections as against.666 and.500 produced by ph 6 and ph 9 respectively emphasizes the need for epitope retrieval for HER-/neu staining, consistent with (Kim et al., 004) where distilled water was used in place of a retrieval buffer solution by both microwave and pressure cooking methods, which resulted in a negative HER-/neu status. Since it was established that demonstration of HER- amplification and overexpression in breast tumours is required to define eligibility for Trastuzumab therapy, nonoptimization of the retrieval ph buffer employed coupled with other factors could lead to a false negative or equivocal HER- status. This makes the patient ineligible for Herceptin therapy, eventually denying women with breast cancer potentially life-extending treatment. Test for the Null Hypothesis to establish the nosignificant difference on the influence of ph buffers on epitope retrieval of HER-/neu protein suggest the retention of the null as seen in Table. This implies that the differences in HER-/neu staining intensity are not significant. Conclusion The ph of the retrieval buffers studied does not significantly influence the staining quality of HER-/neu protein. However, ph 6 buffer appears to be optimal for epitope retrieval of HER-/neu protein. REFERENCES Chazin VR, Kaleko M, Miller AD and Slamon DJ (199). Transformation mediated by the human HER- gene independent of the epidermal growth factor receptor. Oncogen 7:1859 1866. Dapson RW (007). Macromolecular changes caused by formalin fixation and antigen retrieval. Biotech Histochem 8:1 140. Emoto K, Yamashita S and Okada Y (005). Mechanisms of Heat-induced Antigen Retrieval: Does ph or Ionic Strength of the Solution Play a Role for Refolding Antigens? J. Histochem. Cytochem 5: 111. Goldhirsch A, Coates AS, Gelber RD, Glick JH, Thurlimann B and Senn H-J. On behalf of the St Gallen Expert Panel Members. (006). Firstselect the target: better choice of adjuvant treatments for breast cancer patients. Ann Oncol 17:177 1776. Gray SD, Selbie D and Cooper RF (007). Standardized antigen retrieval and immunohistochemical demonstration of tissue antigens using -in-1 buffers in conjunction with a pre-treatment module. Immunohistochemistry 6():58 61. Igarashi H, Sugimura H, Maruyama K, Kitayama Y, Ohta I and Suzuki M (1994). Alteration of immunoreactivity of hydrated autoclaving, microwave treatment, simple heating of paraffin-embedded tissue sections. APMIS 10:95 07. Kakimoto K, Takekoshi S, Miyajima K and Osamura RY (008). Hypothesis for the mechanism of heat-induced antigen retrieval occurring on fresh frozen sections without formalin-fixation in immunohistochemistry. J Mol Histol 9:89 99. Kim SH, Kook MC, Shin YK, Park SH and Song HG (004). Evaluation of antigen retrieval buffer systems. J Mol Histol 5:409 416. Morgan JM, Navabi H and Jasani B (1997). Role of calcium chelation in high-temperature antigen retrieval at different ph values. J Pathol 18: 7. Penault-Llorca F, Vincent-Salomon A, Mathieu MC, Trillet-Lenoir V, Khayat D and Marty M. On behalf of the Esther Study Group. (005). Incidence and implications of HER- and hormonal receptor over-expression in newly diagnosed metastatic breast cancer (MBC). J Clin Oncol :69. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-/neu oncogene. Science 5:177 18. 5